9.2 C
New York
Wednesday, February 8, 2023

Taking On Challenges And Growing? – Banco Macro S.A. (BMA)

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. After-hours trades for Banco Macro S.A. (BMA) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.65, or -3.13%, to $20.10. The Banco Macro S.A. has recorded 3,684 volume in the after hours trading session. Most recently, Yahoo Finance reported about the stock as it publicized that Banco Macro Announces Results for the Third Quarter of 2022.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

Stocks Info

This NYSE-listed company operates within the Banks – Regional industry segment, falling under the Financial sector. At the end of the last regular session, the stock closed at $20.75 and fluctuated between $20.79 as its day high and $19.32 as its day low. The current market capitalization of Banco Macro S.A. is $2.46B. A total of 0.55 million shares were traded on the day, compared to an average of 198.39K shares.

Dividend

The income generated by dividends is an indication that a company is improving its financial position, which is why investors prefer companies paying dividends. Banco Macro S.A. pays an annual dividend of $0.94, resulting in a dividend yield of 4.55%, and it has a price to earnings (P/E) ratio of 6.86. BMA’s most recent ex-dividend date was 12/23/2022 when it declared a $0.0787 quarterly dividend that was paid in cash on 1/4/2023. Previously, the company paid the dividend on 12/2/2022 with an ex-dividend date of 11/23/2022. The BMA stock dividend was $0.0787 per share in cash.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for BMA in the last 3 months, the mean price target is $23.93 with high estimates of $72.77 and low estimates of $3.49. In terms of 52-week highs and lows, BMA has a high of $19.84 and a low of $9.61.

As of this writing, BMA has an earnings estimate of $0.65 per share for the current quarter. EPS was calculated based on a consensus of 3 estimates, with a high estimate of $0.92 per share and a lower estimate of $0.46. The company reported an EPS of $0.88 in the last quarter, which was 57.10% higher than expectations of $0.56.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 8 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BMA is Overweight with a score of 1.33. A total of 2 analysts rated the stock as Buy while 0 rated it as Overweight while 2 rated it as Hold. Among the other participants, 1 thought the stock was Underweight and 3 thought it should be Sold.

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Articles